PUBLIC RELEASE DATE: 20-Oct-2014 Contact: David McKeon 212-365-7440 New York Stem Cell Foundation @nyscf Leaders in translational stem cell research from around the world will present the latest advances in stem cell science that are leading to better treatments and cures to disease and injury at The New York Stem Cell Foundation’s Ninth Annual Translational Stem Cell Research Conference. The opening day of the conference includes a panel discussion on large scale, big data stem cell and genetic initiatives moderated by Susan L.
La Jolla, CA (PRWEB) October 21, 2014 StemGenex, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today announced their newest clinical study in partnership with Stem Cell Research Centre for Osteoarthritis. StemGenex and Stem Cell Research Centre (SCRC) believe that a commitment to the safety and efficacy of stem cell therapy are paramount when providing care to patients with life threatening diseases. There are currently 21 million people in the U.S
Endometriosis is a common yet poorly understood illness that affects women of reproductive age and is often under and misdiagnosed. It is believed that endometrial cells that normally line the uterus grow… Continue Reading Anaphylaxis is the most extreme form of severe allergic reactions which can be life threatening and requires emergency medical treatment
BOTHELL, Wash., Oct. 21, 2014 /PRNewswire/ — BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation ..